Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew X Zhang

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Opinion in Chemical Biology|May 7, 2020
'Design, synthesis, and strategic use of small chemical probes toward identification of novel targets for drug development'Maria Paola Castaldi, James Adam Hendricks, Andrew X Zhang
Biochemical Society Transactions|October 28, 2021
Chemical biology approaches to study histone interactorsAntony J Burton, Ghaith M Hamza, Andrew X Zhang, et al.
ACS Chemical Biology|November 22, 2011
Reprogramming urokinase into an antibody-recruiting anticancer agentCharles E Jakobsche, Patrick J McEnaney, Andrew X Zhang, et al.
ACS Chemical Biology|July 5, 2012
Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human diseasePatrick J McEnaney, Christopher G Parker, Andrew X Zhang, et al.
Journal of the American Chemical Society|November 6, 2009
Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancerRyan P Murelli, Andrew X Zhang, Julien Michel, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 22, 2021
The Vital Role of Proteomics in Characterizing Novel Protein DegradersAndrew X Zhang, Katelyn Cassidy, Göran Dahl, et al.
Journal of the American Chemical Society|August 24, 2010
A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small moleculesAndrew X Zhang, Ryan P Murelli, Cyril Barinka, et al.
British Journal of Pharmacology|February 6, 2020
Proteolysis-targeting chimeras in drug development: A safety perspectiveKevin Moreau, Muireann Coen, Andrew X Zhang, et al.
Journal of the American Chemical Society|December 17, 2014
Chemically synthesized molecules with the targeting and effector functions of antibodiesPatrick J McEnaney, Kelly J Fitzgerald, Andrew X Zhang, et al.
ACS Chemical Biology|July 23, 2019
CETSA beyond Soluble Targets: a Broad Application to Multipass Transmembrane ProteinsAarti Kawatkar, Michelle Schefter, Nils-Olov Hermansson, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Opinion in Chemical Biology|May 7, 2020
'Design, synthesis, and strategic use of small chemical probes toward identification of novel targets for drug development'Maria Paola Castaldi, James Adam Hendricks, Andrew X Zhang
Biochemical Society Transactions|October 28, 2021
Chemical biology approaches to study histone interactorsAntony J Burton, Ghaith M Hamza, Andrew X Zhang, et al.
ACS Chemical Biology|November 22, 2011
Reprogramming urokinase into an antibody-recruiting anticancer agentCharles E Jakobsche, Patrick J McEnaney, Andrew X Zhang, et al.
ACS Chemical Biology|July 5, 2012
Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human diseasePatrick J McEnaney, Christopher G Parker, Andrew X Zhang, et al.
Journal of the American Chemical Society|November 6, 2009
Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancerRyan P Murelli, Andrew X Zhang, Julien Michel, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 22, 2021
The Vital Role of Proteomics in Characterizing Novel Protein DegradersAndrew X Zhang, Katelyn Cassidy, Göran Dahl, et al.
Journal of the American Chemical Society|August 24, 2010
A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small moleculesAndrew X Zhang, Ryan P Murelli, Cyril Barinka, et al.
British Journal of Pharmacology|February 6, 2020
Proteolysis-targeting chimeras in drug development: A safety perspectiveKevin Moreau, Muireann Coen, Andrew X Zhang, et al.
Journal of the American Chemical Society|December 17, 2014
Chemically synthesized molecules with the targeting and effector functions of antibodiesPatrick J McEnaney, Kelly J Fitzgerald, Andrew X Zhang, et al.
ACS Chemical Biology|July 23, 2019
CETSA beyond Soluble Targets: a Broad Application to Multipass Transmembrane ProteinsAarti Kawatkar, Michelle Schefter, Nils-Olov Hermansson, et al.
Pageof 3